Exploring the potential of endophytes from medicinal plants as sources of antimycobacterial compounds

Microbiological Research

Volumn 169, Issue 7-8, 2014, Pages 483-495

  Alvin, Alfonsus ^a   Miller, Kristin I ^a   Neilan, Brett A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Endophytes; Natural products; Tuberculosis

Indexed keywords

MICROORGANISMS; PATHOGENS; PEPTIDES;

ANTI-MYCOBACTERIAL; CURRENT TREATMENTS; ENDOPHYTES; MICROBIAL PATHOGENS; MYCOBACTERIUM TUBERCULOSIS; NATURAL PRODUCTS; STRUCTURAL DIVERSITY; TUBERCULOSIS;

PLANTS (BOTANY);

DISEASE CONTROL; ENDOPHYTE; IDENTIFICATION METHOD; MEDICINAL PLANT; PATHOGEN; PEPTIDE; SYMPTOM; TAXONOMY;

MYCOBACTERIUM TUBERCULOSIS;

ANTIINFECTIVE AGENT;

ANIMAL; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; ENDOPHYTE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG DISCOVERY; ENDOPHYTES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PLANTS, MEDICINAL; TUBERCULOSIS;

EID: 84899987067     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2013.12.009     Document Type: Article

References (179)

1. Alahari A., Alibaud L., Trivelli X., Gupta R., Lamichhane G., Reynolds R.C., et al. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis. Molecular Microbiology 2009, 71:1263-1277.
2. Alangaden G.J., Manavathu E.K., Vakulenko S.B., Zvonok N.M., Lerner S.A. Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrobial Agents and Chemotherapy 1995, 39:1700-1703.
3. Alangaden G.J., Kreiswirth B.N., Aouad A., Khetarpal M., Igno F.R., Moghazeh S.L., et al. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 1998, 42:1295-1297.
4. Alcorn J.B. The scope and aims of ethnobotany in a developing world. Ethnobotany: evolution of a discipline 1995, 23-39. Chapman & Hall, London. R.E. Schultes, S. von Reis (Eds.).
5. Amaral L. Totally drug resistant tuberculosis can be treated with thioridazine in combination with antibiotics to which the patient was initially resistant. Biochemistry and Pharmacology 2012, 1:10001102.
6. Andini N., Nash K.A. Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. Antimicrobial Agents and Chemotherapy 2006, 50:2560-2562.
7. Andries K., Verhasselt P., Guillemont J., Göhlmann H.W.H., Neefs J.M., Winkler H., et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005, 307:223-227.
8. 37Ra and cytotoxic activity. Journal of Agricultural and Food Chemistry 2012, 60:9834-9841.
9. Ashforth E.J., Fu C., Liu X., Dai H., Song F., Guo H., et al. Bioprospecting for antituberculosis from microbial metabolites. Natural Product Reports 2010, 27:1709-1719.
10. Aubry A., Veziris N., Cambau E., Truffot-Pernot C., Jarlier V., Fisher L.M., et al. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrobial Agents and Chemotherapy 2006, 50:104-112.
11. Azevedo J.L., Maccheroni W., Pereira J.O., de Araújo W.L. Endophytic microorganisms: a review on insect control and recent advances on tropical plants. Electronic Journal of Biotechnology 2000, 3:40-65.
12. Baker D., Mocek U., Garr C. Natural products vs. combinatorials: a case study. Biodiversity: new leads for pharmaceutical and agrochemical industries 2000, 66-72. Royal Society of Chemistry, Cambridge. S.K. Wrigley, M.A. Hayes, R. Thomas, E.J.T. Chrystal, N. Nicholson (Eds.).
13. Banerjee A., Dubnau E., Quemard A., Balasubramainan V., Um K.S., Wilson T., et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994, 263:227-230.
14. Barbachyn M.R., Hutchinson D.K., Brickner S.J., Cynamon M.H., Kilburn J.O., Klemens S.P., et al. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. Journal of Medicinal Chemistry 1996, 39:680-685.
15. Barry C.E., Blanchard J.S. The chemical biology of new drugs in the development for tuberculosis. Current Opinion in Chemical Biology 2010, 14:456-466.
16. Baulard A.R., Betts J.C., Engohang-Ndong J., Quan S., Mcadam R.A., Brennan P.J., et al. Activation of the pro-drug ethionamide is regulated in mycobacteria. Journal of Biological Chemistry 2000, 275:28326-28331.
17. Berg G., Hallmann J. Control of plant pathogenic fungi with bacterial endophytes. Microbial root endophytes 2006, 53-69. Springer-Verlag, Berlin. B. Schulz, C. Boyle, T. Sieber (Eds.).
18. Bergval I.L., Schuitema A.R.J., Klatser P.R., Anthony R.M. Resistant mutant of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance. Journal of Antimicrobial Chemotherapy 2009, 64:515-523.
19. Bisang C., Long P.F., Cortés J., Westcott J., Crosby J., Matharu A.L., et al. A chain initiation factor common to both modular and aromatic polyketide synthases. Nature 1999, 401:502-505.
20. Bisht D., Owais M., Venkatesan K. Potential of plant-derived products in the treatment of mycobacterial infections. Modern phytomedicine: turning medicinal plants into drugs 2006, 293-312. Wiley-VCH, Weinheim. I. Ahmad, F. Aqil, M. Owais (Eds.).
21. Bömke C., Tudzynski B. Diversity, regulation, and evolution of the gibberellin biosynthetic pathway in fungi compared to plants and bacteria. Phytochemistry 2009, 70:1876-1893.
22. Boshoff H.I., Myers T.G., Copp B.R., Mcneil M.R., Wilson M.A., Barry C.E., et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. Journal of Biological Chemistry 2004, 279. 40174-10184.
23. Bunyapaiboonsri T., Veeranondha S., Boonruangprapa T., Somrithipol S. Ramiferin, a bisphenol-sesquiterpene from the fungus Kionochaeta ramifera BCC 7585. Phytochemistry Letters 2008, 1:204-206.
24. Cáceres N.E., Harris N.B., Wellehan J.F., Feng Z.Y., Kapur V., Barletta R.G. Overexpression of the d-alanine racemase gene confers resistance to d-cycloserine in Mycobacterium smegmatis. Journal of Bacteriology 1997, 179:5046-5055.
25. Cane D.E. Programming of erythromycin biosynthesis by a modular polyketide synthase. Journal of Biological Chemistry 2010, 285:27517-27523.
26. Centko R.M., Ramón-García S., Taylor T., Patrick B.O., Thompson C.J., Miao V.P., et al. Ramariolides A-D, antimycobacterial butenolides isolated from the mushroom Ramaria cystidiophora. Journal of Natural Products 2012, 75:2178-2182.
27. Chan Y.A., Podevels A.M., Kevany B.M., Thomas M.G. Biosynthesis of polyketide synthase extender units. Natural Product Reports 2009, 26:90-114.
28. Changsen C., Franzblau S.G., Palittapongarnpim P. Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter. Antimicrobial Agents and Chemotherapy 2003, 47:3682-3687.
29. Cheng Y.Q. Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC15141. ChemBioChem 2006, 7:471-477.
30. Cheng M.J., Wu M.D., Yanai H., Su Y.S., Chen I.S., Yuang G.F., et al. Secondary metabolites from the endophytic fungus Biscogniauxia formosana and their antimycobacterial activity. Phytochemistry Letters 2012, 5:467-472.
31. Cholo M.C., Boshoff H.I., Steel H.C., Cockeran R., Matlola N.M., Downing K.J., et al. Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy 2006, 57:79-84.
32. Cohen J. Approval of novel TB drug celebrated - with restraint. Science 2013, 339:130.
33. Copp B.R., Pearce A.N. Natural product growth inhibitors of Mycobacterium tuberculosis. Journal of Natural Products 2007, 24:278-297.
34. Dalimartha S. Atlas Tumbuhan Obat Indonesia 1999, Trubus Agriwidya, Jakarta.
35. Dalimartha S. Atlas Tumbuhan Obat Indonesia 2000, Trubus Agriwidya, Jakarta.
36. Dalimartha S. Atlas Tumbuhan Obat Indonesia 2003, Puspa Swara, Jakarta.
37. Dalimartha S. Atlas Tumbuhan Obat Indonesia 2006, Puspa Swara, Jakarta.
38. Dalimartha S. Atlas Tumbuhan Obat Indonesia 2008, Pustaka Bunda, Jakarta.
39. Dalimartha S. Atlas Tumbuhan Obat Indonesia 2009, Pustaka Bunda, Jakarta.
40. Dančík V., Seiler K.P., Young D.W., Schreiber S.L., Clemons P.A. Distinct biological network properties between the targets of natural products and disease genes. Journal of the American Chemical Society 2010, 132:9259-9261.
41. Danziger L.H., Neuhauser M. Beta-lactam antibiotics. Drug interactions in infectious diseases 2011, 203-242. Humana Press, New York. S.C. Piscitelli, K.A. Rodvold, M.P. Pai (Eds.).
42. Davis E.W. Ethnobotany: an old practice, a new discipline. Ethnobotany: evolution of a discipline 1995, 40-51. Chapman & Hall, London. R.E. Schultes, S. von Reis (Eds.).
43. Plant resources of South-East Asia: medicinal and poisonous plants 1 1999, Bogor, Prosea. L.S. de Padua, N. Bunyapraphatsara, R.H.M.J. Lemmens (Eds.).
44. Debarber A.E., Mdluli K., Bosman M., Bekker L.G., Barry C.E. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:9677-9682.
45. Demain A.L. Microbial natural products: a past with a future. Biodiversity: new leads for pharmaceutical and agrochemical industries 2000, 3-16. Royal Society of Chemistry, Cambridge. S.K. Wrigley, M.A. Hayes, R. Thomas, E.J.T. Chrystal, N. Nicholson (Eds.).
46. Diacon A.H., Pym A., Grobusch M., Patientia R., Rustomjee R., Page-Shipp L., et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. New England Journal of Medicine 2009, 360:2397-2405.
47. Diacon A.H., Donald P.R., Pym A., Grobusch M., Patientia R., Mahanyele R., et al. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrobial Agents and Chemotherapy 2012, 56:3271-3276.
48. Domenech P., Barry C.E., Cole S.T. Mycobacterium tuberculosis in the post-genomic age. Current Opinion in Microbiology 2001, 4:28-34.
49. Drlica K., Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews 1997, 61:377-392.
50. Engelberg-Kulka H., Sat B., Reches M., Amitai S., Hazan R. Bacterial programmed cell death systems as targets for antibiotics. Trends in Microbiology 2004, 12:66-71.
51. Engohang-Ndong J., Baillat D., Aumercier M., Bellefontaine F., Besra G.S., Locht C., et al. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator. Molecular Microbiology 2004, 51:175-188.
52. Farnsworth N.R., Akerele O., Bingel A.S., Soejarto D.D., Guo Z. Medicinal plants in therapy. Bulletin of the World Health Organization 1985, 63:965-981.
53. Felnagle E.A., Rondon M.R., Berti A.D., Crosby H.A., Thomas M.G. Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycin. Applied and Environmental Microbiology 2007, 73:4162-4170.
54. Finken M., Kirschner P., Meier A., Wrede A., Böttger E.C. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Molecular Microbiology 1993, 9:1239-1246.
55. Fischbach M.A., Walsh C.T. Asembly-line enzymology for polyketide and nonribosomal peptide antiobiotics: logic, machinery, and mechanisms. Chemical Reviews 2006, 106:2468-3496.
56. Fleming A. On the antibacterial action of the cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. British Journal of Experimental Pathology 1929, 10:226-236.
57. Frieden T.R., Sterling T.R., Munsiff S.S., Watt C.J., Dye C. Tuberculosis. Lancet 2003, 362:887-899.
58. Gallop M.A., Barrett R.W., Dower W.J., Fodor S.P.A., Gordon E.M. Application of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. Journal of Medicinal Chemistry 1994, 37:1233-1251.
59. Gil J.A., Martín J.F. Polyene antibiotics. Biotechnology of Antibiotics 1997, 551-575. Marcel Dekker Inc., New York. 2nd ed. W.R. Strohl (Ed.).
60. Gita Bangera M., Thomashow L.S. Identification and characterization of a gene cluster for synthesis of the polyketide antibiotic 2, 4-diacetylphloroglucinol from Pseudomonas fluorescens Q2-87. Journal of Bacteriology 1999, 181:3155-3163.
61. Gler M.T., Skripconoka V., Sanchez-Garavito E., Xiao H.P., Cabrera-Rivero J.L., Vargas-Vasquez D.E., et al. Delamanid for multidrug-resistant pulmonary tuberculosis. New England Journal of Medicine 2012, 366:2151-2160.
62. Glick B.R., Penrose D.M., Li J.P. A model for the lowering of plant ethylene concentrations by plant growth-promoting bacteria. Journal of Theoretical Biology 1998, 190:63-68.
63. Gordon B. Jeweller of the jungle 2007, vol. 59:38-45. Americas (English edition).
64. Grimm A., Madduri K., Ali A., Hutchinson C.R. Characterization of the Streptomyces peucetius ATCC 29050 genes encoding doxorubicin polyketide synthase. Gene 1994, 151:1-10.
65. Gross H., Loper J.E. Genomics of secondary metabolite production by Pseudomonas spp. Natural Product Reports 2009, 26:1408-1446.
66. Grosset J. Current problems with tuberculosis treatment. Research in Microbiology 1996, 147:10-16.
67. Gunther E. Ethnobotany of western Washington 1945, vol. 10:1-62. University of Washington Publications in Anthropology.
68. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular Aspects of Medicine 2006, 27:1-93.
69. Hallmann J., Quadt-Hallman A., Rodríguez-Kábana R., Kloepper J.W. Interactions between Meloidogyne incognita and endophytic bacteria in cotton and cucumber. Soil Biology and Biochemistry 1998, 30:925-937.
70. Halouska S., Chacon O., Fenton R.J., Zinniel D.K., Barletta R.G., Powers R., et al. Use of NMR metabolomics to analyze the targets of d-cycloserine in mycobacteria: role of d-alanine racemase. Journal of Proteome Research 2007, 6:4608-4614.
71. Haritakun R., Sappan M., Suvannakad R., Tasanathai K., Isaka M. An antimycobacterial cyclodepsipeptide from the entomopathogenic fungus Ophiocordyceps communis BCC 16475. Journal of Natural Products 2010, 73:75-78.
72. Haritakun R., Rachtawee P., Komwijit S., Nithithanasilp S., Isaka M. Highly conjugated ergostane-type steroids and aranotin-type diketopiperazines from the fungus Aspergillus terreus BCC 4651. Helvetica Chimica Acta 2012, 95:308-313.
73. Heifets L., Lindholm-Levy P. Pyrazinamide sterilizing activity in vitro against semi-dormant Mycobacterium tuberculosis bacterial populations. American Review of Respiratory Diseases 1992, 145:1223-1225.
74. Heinig U., Scholz S., Jennewein S. Getting to the bottom of Taxol biosynthesis by fungi. Fungal Diversity 2013, 60:161-170.
75. Hertweck C., Luzhetskyy A., Rebets Y., Bechthold A. Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork. Natural Product Reports 2007, 24:162-190.
76. Hoffmeister D., Keller N.P. Natural products of filamentous fungi: enzymes, genes, and their regulation. Natural Product Reports 2007, 24:393-416.
77. Huitric E., Verhasselt P., Koul A., Andries K., Hoffner S., Andersson D.I. Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor. Antimicrobial Agents and Chemotherapy 2010, 54:1022-1028.
78. Isaka M., Palasarn S., Supothina S., Komwijit S., Luangsa-ard J.J. Bioactive compounds from the scale insect pathogenic fungus Conoideocrella tenuis BCC 18627. Journal of Natural Products 2011, 74:782-789.
79. Jarlier V., Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiology Letters 1994, 123:11-18.
80. Jones D. Tuberculosis success. Nature Reviews Drug Discovery 2013, 12:175-176.
81. Khumkomkhet P., Kanokmedhakul S., Kanokmedhakul K., Hahnvajanawong C., Soytong K. Antimalarial and cytotoxic depsidones from the fungus Chaetomium brasiliense. Journal of Natural Products 2009, 72:1487-1491.
82. Kingston D.G.I. Modern natural products drug discovery and its relevance to biodiversity conservation. Journal of Natural Products 2011, 74:496-511.
83. Kloepper J.W., Ryu C.M. Bacterial endophytes as elicitors of induced systemic resistance. Microbial root endophytes 2006, 33-52. Springer-Verlag, Berlin. B. Schulz, C. Boyle, T. Sieber (Eds.).
84. Koul A., Vranckx L., Dendouga N., Balemans W., Van Den Wyngaert I., Vergauwen K., et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostatis. Journal of Biological Chemistry 2008, 283:25273-25280.
85. Koul A., Arnoult E., Lounis N., Guillemont J., Andries K. The challenge of new drug discovery for tuberculosis. Nature 2011, 469:483-490.
86. Koyama N., Kojima S., Nonaka K., Masuma R., Matsumoto M., Omura S., et al. Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905. Journal of Antibiotics 2010, 63:183-186.
87. Kunin C.M. Antimicrobial activity of rifabutin. Clinical Infectious Diseases 1996, 22:S3-S14.
88. Kusari S., Verma V.C., Lamshoeft M., Spiteller M. An endophytic fungus from Azadirachta indica A. Juss. that produces azadirachtin. World Journal of Microbiology and Biotechnology 2012, 28:1287-1294.
89. Lee R.E., Mikušová K., Brennan P.J., Besra G.S. Synthesis of the mycobacterial arabinose donor β-d-arabinofuranosyl-1-monophosphoryldecaprenol, development of a basic arabinosyl-transferase assay, and identification of ethambutol as an arabinosyl transferase inhibitor. Journal of the American Chemical Society 1995, 117:11829-11832.
90. Lenaerts A.J.M., Gruppo V., Brooks J.V., Orme I.M. Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice. Antimicrobial Agents and Chemotherapy 2003, 47:783-785.
91. Limyati D.A., Juniar B.L.L. Jamu Gendong, a kind of traditional medicine in Indonesia: the microbial contamination of its raw materials and end product. Journal of Ethnopharmacology 1998, 63:201-208.
92. Liou Y.F., Tanaka N. Dual actions of viomycin on the ribosomal functions. Biochemical and Biophysical Research Communications 1976, 71:477-483.
93. Louw G.E., Warren R.M., van Pittius N.C.G., Mcevoy C.R.E., van Helden P.D., Victor T.C., et al. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrobial Agents and Chemotherapy 2009, 53:3181-3189.
94. Mandal S., Moudgil M., Mandal S.K. Rational drug design. European Journal of Pharmacology 2009, 625:90-100.
95. Manjunatha U., Boshoff H.I., Dowd C.S., Zhang L., Albert T.J., Norton J.E., et al. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:431-436.
96. Manjunatha U., Boshoff H.I., Barry C.E. The mechanism of action of PA-824: novel insights from transcriptional profiling. Communicative & Integrative Biology 2009, 2:215-218.
97. Maroz A., Shinde S.S., Franzblau S.G., Ma Z.K., Denny W.A., Palmer B.D., et al. Release of nitrite from the antitubercular nitroimidazole drug PA-824 and analogues upon one-electron reduction in protic, non-aqueous solvent. Organic & Biomolecular Chemistry 2010, 8:413-418.
98. Martin G.E. Small-volume and high-sensitivity NMR probes. Annual Reports on NMR Spectroscopy 2005, 56:1-96.
99. Mathys V., Wintjens R., Lefevre P., Bertout J., Singhal A., Kiass M., et al. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 2009, 53:2100-2109.
100. Matsumoto M., Hashizume H., Tomishige T., Kawasaki M., Tsubouchi H., Sasaki H., et al. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. Public Library of Science Medicine 2006, 3:e466.
101. Mcalpine J.B., Pazoles C., Stafford A. Phytera's strategy for the discovery of novel anti-infective agents from plant cell cultures. Bioassay method in natural product research and drug development 1999, Kluwer Academic Publishers, Dordrecht. L. Bohlin, J.G. Bruhn (Eds.).
102. Meier A., Kirschner P., Springer B., Steingrube V.A., Brown B.A., Wallace R.J., et al. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrobial Agents and Chemotherapy 1994, 38:381-384.
103. Miao V., Coëffet-LeGal M.F., Brian P., Brost R., Penn J., Whiting A., et al. Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology 2005, 151:1507-1523.
104. Miller K.I., Qing C., Sze D.M.Y., Roufogalis B.D., Neilan B.A. Culturable endophytes of medicinal plants and the genetic basis for their bioactivity. Microbial Ecology 2012, 64:431-449.
105. Mootz H.D., Schwarzer D., Marahiel M.A. Ways of assembling complex natural products on modular nonribosomal peptide synthetases. ChemBioChem 2002, 3:490-504.
106. Mukai A., Fukai T., Hoshino Y., Yazawa K., Harada K., Mikami Y., et al. Nocardithiocin, a novel thiopeptide antibiotic, produced by pathogenic Nocardia pseudobrasiliensis IFM 0757. Journal of Antibiotics 2009, 62:613-619.
107. Müller B.A. Imatinib and its successors - how modern chemistry has changed drug development. Current Pharmaceutical Design 2009, 15:120-133.
108. Myers N., Mittermeier R.A., da Fonseca G.A.B., Kent J. Biodiversity hotspots for conservation priorities. Nature 2000, 403:853-858.
109. Nakajima Y. Mechanisms of bacterial resistance to macrolide antibiotics. Journal of Infection and Chemotherapy 1999, 5:61-74.
110. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products 2010, 75:311-335.
111. Osborne R. First novel anti-tuberculosis drug in 40 years. Nature Biotechnology 2013, 31:89-91.
112. O'sullivan D.J., O'gara F. Traits of fluorescent Pseudomonas spp. involved in suppression of plant root pathogens. Microbiological Reviews 1992, 56:662-676.
113. Paradkar A.S., Jensen S.E., Mosher R.H. Comparative genetics and molecular biology of β-lactam biosynthesis. Biotechnology of Antibiotics 1997, 241-277. Marcel Dekker Inc., New York. 2nd ed. W.R. Strohl (Ed.).
114. Patel U., Yan Y.P., Hobbs F.W., Kaczmarczyk J., Slee A.M., Pompliano D.L., et al. Oxazolidinones mechanism of action: inhibition of the first peptide bond formation. Journal of Biological Chemistry 2001, 276:37199-37205.
115. Pestka S. Inhibitors of protein synthesis. Molecular mechanisms of protein biosynthesis 1977, 467-553. Academic Press, New York. H. Weissbach, S. Pestka (Eds.).
116. Phetsuksiri B., Jackson M., Scherman H., Mcneil M., Besra G.S., Baulard A.R., et al. Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis. Journal of Biological Chemistry 2003, 278:53123-53130.
117. Phonkerd N., Kanokmedhakul S., Kanokmedhakul K., Soytong K., Prabpai S., Kongsaeree P. Bis-spiro-azaphilones and azaphilones from the fungi Chaetomium cochliodes VTh01 and C. cochliodes CTh05. Tetrahedron 2008, 64:9636-9645.
118. Pittayakhajonwut P., Sohsomboon P., Dramae A., Suvannakad R., Lapanun S., Tantichareon M. Antimycobacterial substances from Phaeosphaeria sp BCC8292. Planta Medica 2008, 74:281-286.
119. Pruksakorn P., Arai M., Kotoku N., Vilchèze C., Baughn A.D., Moodley P., et al. Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria. Bioorganic and Medicinal Chemistry Letters 2010, 20:3658-3663.
120. Puri S.C., Verma V., Amna T., Qazi G.N., Spiteller M. An endophytic fungus from Nothapodytes foetida that produces camptothecin. Journal of Natural Products 2005, 68:1717-1719.
121. Puri S.C., Nazir A., Chawla R., Arora R., Riyaz-ul-Hasan S., Amna T., et al. The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryl tetralin lignans. Journal of Biotechnology 2006, 122:494-510.
122. Raja A., Labonte J., Lebbos J., Kirkpatrick P. Daptomycin. Nature Reviews Drug Discovery 2003, 2:943-944.
123. Ramaswamy S.V., Amin A.G., Göksel S., Stager C.E., Dou S.J., El Sahly H., et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 2000, 44:326-336.
124. Rattan A., Kalia A., Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular prespectives. Emerging Infectious Diseases 1998, 4:195-209.
125. Rawlings B.J. Type I polyketide biosynthesis in bacteria (Part A - erythromycin biosynthesis). Natural Product Reports 2001, 18:190-227.
126. Reddy V.M., Nadadhur G., Gangadharam P.R.J. In vitro and intracellular antimycobacterial activity of trifluoperazine. Journal of Antimicrobial Chemotherapy 1996, 37:196-197.
127. Rengarajan J., Sassetti C.M., Naroditskaya V., Sloutsky A., Bloom B.R., Rubin E.J. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Molecular Microbiology 2004, 53:275-282.
128. Richardson A.E., Barea J.M., Mcneill A.M., Prigent-Combaret C. Acquisition of phosphorus and nitrogen in the rhizosphere and plant growth promotion by microorganisms. Plant Soil 2009, 321:305-339.
129. Richter E., Rüsch-Gerdes S., Hillemann D. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 2007, 51:1534-1536.
130. Rouse D.A., Li Z., Bai G.H., Morris S.L. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 1995, 39:2472-2477.
131. Rozwarski D.A., Grant G.A., Barton D.H.R., Jacobs W.R., Sacchettini J.C. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 1998, 279.
132. Rukachaisirikul V., Sommart U., Phongpaichit S., Sakayaroj J., Kirtikara K. Metabolites from the endophytic fungus Phomopsis sp. PSU-D15. Phytochemistry 2008, 69:783-787.
133. Ryan R.P., Germaine K., Franks A., Ryan D.J., Dowling D.N. Bacterial endophytes: recent developments and applications. FEMS Microbiology Letters 2008, 278:1-9.
134. Sacksteder K.A., Protopopova M., Barry C.E., Andries K., Nacy C.A. Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. Future Medicine 2012, 7:823-837.
135. Salim A.A.W.C.Y., Kinghorn A.D. Drug discovery from plants. Bioactive molecules and medicinal plants 2008, 1-24. Springer, Berlin. K.G. Ramawat, J.M. Mérillon (Eds.).
136. Salomon C.E., Schmidt L.E. Natural products as leads for tuberculosis drug development. Current Topics in Medicinal Chemistry 2012, 12:735-765.
137. Schaeffer M.L., Carson J.D., Kallender H., Lonsdale J.T. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis. Tuberculosis 2004, 84:353-360.
138. Scherman M.S., Winans K.A., Stern R.J., Jones V., Bertozzi C.R., Mcneil M.R. Drug targeting Mycobacterium tuberculosis cell wall synthesis: development of a microtiter plate-based screen for UDP-galactopyranose mutase and identification of an inhibitor from a uridine-based library. Antimicrobial Agents and Chemotherapy 2003, 47:378-382.
139. Schulz B., Boyle C. What are endophytes?. Microbial root endophytes 2006, 1-13. Springer-Verlag, Berlin. B. Schulz, C. Boyle, T. Sieber (Eds.).
140. Schumacher T. Plants used in medicine. Indonesian heritage: plants 1999, 68-69. Archipelago Press, Singapore. T. Whitten, J. Whitten (Eds.).
141. Scorpio A., Lindholm-Levy P., Heifets L., Gilman R., Siddiqi S., Cynamon M.H., et al. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 1997, 41:540-543.
142. Shaw K.J., Rather P.N., Hare R.S., Miller G.H. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiological Reviews 1993, 57:138-163.
143. Shinabarger D.L., Marotti K.R., Murray R.W., Lin A.H., Melchior E.P., Swaney S.M., et al. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrobial Agents and Chemotherapy 1997, 41:2132-2136.
144. Siciliano S.D., Fortin N., Mihoc A., Wisse G., Labelle S., Beaumier D., et al. Selection of specific endophytic bacterial genotypes by plants in response to soil contamination. Applied and Environmental Microbiology 2001, 67:2469-2475.
145. Singh S.B., Pelaez F. Biodiversity, chemical diversity, and drug discovery. Progress in Drug Research 2008, 65:143-174.
146. Singh R., Manjunatha U., Boshoff H.I., Ha Y.H., Niyomrattanakit P., Ledwidge R., et al. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 2008, 322:1392-1395.
147. Stanikunaite R., Radwan M.M., Trappe J.M., Fronczek F., Ross S.A. Lanostane-type triterpenes from the mushroom Astraeus pteridis with antituberculosis activity. Journal of Natural Products 2008, 71:2077-2079.
148. Steffan B., Wätjen W., Michels G., Niering P., Wray V., Ebel R., et al. Polyphenols from plants used in traditional Indonesian medicine (Jamu): uptake and antioxidative effects in rat H4IIE hepatoma cells. Journal of Pharmacy and Pharmacology 2005, 57:233-240.
149. Stevensen C. Jamu: an Indonesian herbal tradition with a long past, a little known present and an uncertain future. Complementary Therapies in Nursing and Midwifery 1999, 5:1-3.
150. Stierle A., Strobel G., Stierle D., Grothaus P., Bignami G. The search for a taxol-producing microorganism among the endophytic fungi of the Pacific yew, Taxus brevifolia. Journal of Natural Products 1995, 58:1315-1324.
151. Stone J.K., Bacon C.W., White J.F. An overview of endophytic microbes: endophytism defined. Microbial endophytes 2000, 3-30. Dekker, New York. C.W. Bacon, J.F. White (Eds.).
152. Stover C.K., Warrener P., Vandevanter D.R., Sherman D.R., Arain T.M., Langhorne M.H., et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 2000, 405:962-966.
153. Strobel G.A. Endophytes as sources of bioactive products. Microbes and Infection 2003, 5:535-544.
154. Strobel G.A., Daisy B. Bioprospecting for microbial endophytes and their natural products. Microbiology and Molecular Biology Reviews 2003, 67:491-502.
155. Strobel G., Daisy B., Castillo U., Harper J. Natural products from endophytic microorganisms. Journal of Natural Products 2004, 67:257-268.
156. Strohl W.R. The role of natural products in a modern drug discovery program. Drug Discovery Today 2000, 5:39-41.
157. Taghavi S., Barac T., Greenberg B., Borremans B., Vangronsveld J., van der Lelie D. Horizontal gene transfer to endogenous endophytic bacteria from poplar improves phytoremediation of toluene. Applied and Environmental Microbiology 2005, 71:8500-8505.
158. Tahlan K., Wilson R., Kastrinsky D.B., Arora K., Nair V., Fischer E., et al. SQ 109 MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 2012, 56:1797-1809.
159. Takayama K., Schnoes H.K., Armstrong E.L., Boyle R.W. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. Journal of Lipid Research 1975, 16:308-317.
160. Taniguchi H., Chang B., Abe C., Nikaido Y., Mizuguchi Y., Yoshida S.I. Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system. Journal of Bacteriology 1997, 179:4795-4801.
161. Taubman S.B., Jones N.R., Young F.E., Corcoran J.W. Sensitivity and resistance to erythromycin in Bacillus subtilis 168: the ribosomal binding of erythromycin and chloramphenicol. Biochimica et Biophysica Acta 1966, 123:438-440.
162. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S.T., Colston M.J., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993, 341:647-650.
163. Thomas M.G., Chan Y.A., Ozanick S.G. Deciphering tuberactinomycin biosynthesis: isolation, sequencing, and annotation of the viomycin biosynthetic gene cluster. Antimicrobial Agents and Chemotherapy 2003, 47:2823-2830.
164. Tudzynski B. Fungal phytohormones in pathogenic and mutualistic associations. The Mycota V: plant relationships part A 1997, 167-184. Springer-Verlag, Berlin. G.C. Carroll, P. Tudzynski (Eds.).
165. Verpoorte R. Pharmacognosy in the new millennium: leadfinding and biotechnology. Journal of Pharmacy and Pharmacology 2000, 52:253-262.
166. Walker K., Croteau R. Taxol biosynthetic genes. Phytochemistry 2001, 58:1-7.
167. Walters W.P., Namchuk M. Designing screens: how to make your hits a hit. Nature Reviews Drug Discovery 2003, 2:259-266.
168. Wani M.C., Taylor H.L., Wall M.E., Coggon P., Mcphail A.T. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. Journal of the American Chemical Society 1971, 93:2325-2327.
169. Wank H., Rogers J., Davies J., Schroeder R. Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicing. Journal of Molecular Biology 1994, 236:1001-1010.
170. Wiyakrutta S., Sriubolmas N., Phanput W., Thongon N., Danwisetkanjana K., Ruangrungsi N., et al. Endophytic fungi with anti-microbiall, anti-cancer, and anti-malarial activities isolated from Thai medicinal plants. World Journal of Microbiology and Biotechnology 2004, 20:265-272.
171. Wolucka B.A., Mcneil M.R., de Hoffmann E., Chojnacki T., Brennan P.J. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. Journal of Biological Chemistry 1994, 269:23328-23335.
172. World Health Organization Global tuberculosis control 2011, World Health Organization, Geneva.
173. Xie Y., Xu H., Sun C., Yu Y., Chen R. Two novel nucleosidyl-peptide antibiotics: sansanmycin F and G produced by Streptomyces sp SS. Journal of Antibiotics 2010, 63:143-146.
174. Xu H.B., Jiang R.H., Xiao H.P. Clofazimine in the treatment of multidrug-resistant tuberculosis. Clinical Microbiology and Infection 2011.
175. Yamada T., Mizugichi Y., Nierhaus K.H., Wittmann H.G. Resistance to viomycin conferred by RNA of either ribosomal subunit. Nature 1978, 275:460-461.
176. Yano T., Li L.S., Weinstein E.A., Teh J.S., Rubin H. Steady-state kinetics and inhibitory action of antitubercular phenotiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). Journal of Biological Chemistry 2006, 281:11456-11463.
177. Zhang Y., Mitchison D. The curious characteristics of pyrazinamide: a review. International Journal of Tuberculosis and Lung Disease 2003, 7:6-21.
178. Zhang Y., Heym B., Allen B., Young D., Cole S.T. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992, 358:591-593.
179. Zhang Y., Scorpio A., Nikaido H., Sun Z. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. Journal of Bacteriology 1999, 181:2044-2049.